Tauriga Sciences, Inc. engages in the development, distribution, and licensing of proprietary products. It also engages in evaluation of potential acquisition opportunities and equity investments. The firm focuses on biotherapeutics and diagnostics, medical devices, and consumer healthcare. Its products include Tauri-GUM which contains cannabidoil. The company was founded on April 8, 2001 and is headquartered in New York, NY.